A Prospective Investigation of the VWF-ADAMTS 13 Axis in Acute Ischaemic Brain Injury (TIAs and Stroke).

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In patients presenting with acute stroke or transient ischaemic attacks (TIA), von Willebrand factor related parameters, including VWF antigen, activity, FVIII:c and propeptides, ADAMTS13 levels and VWF multimers in cases where ADAMTS 13 was reduced will be measured. Global haemostasis will be assessed using thrombin generation and the relation between increase thrombin generation and VWF explored. Thrombin generation will be performed pre and post filtration for the presence of procoagulant microparticles. These parameters will be investigated acutely, at presentation and in convalescence; in addition, the effect on these parameters of treatment such as thrombolysis may be informative. Correlation between measured parameters and adverse clinical outcome would be used to identify markers of severity and progression of ischaemic stroke and identification of potential novel approaches to therapy that might improve outcome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study

NCT03937947

Traumatic Brain Injury Deep Vein Thrombosis Acute Lung Injury +1 more

COMPLETED

Platelet Activation in Delayed Cerebral Ischemia Secondary to Aneurysmal Subarachnoid Hemorrhage

NCT06375889

Aneuvrysmal Subarachnoid Hemorrhage Delayed Cerebral Ischemia Endotheliopathy +1 more

COMPLETED

Prehospital Advanced Diagnostics and Treatment of Acute Stroke

NCT03158259

Ischemic (Brain) Stroke Hemorrhagic Stroke TIA, Brain

UNKNOWN NA

CT Based Definition of a Tissue Window for Acute Stroke Thrombolysis

NCT00463281

Stroke

COMPLETED

Evaluation of the HARM for the Detection of a Cerebral Ischemia in TIA/TNA Patients

NCT03555643

TIA Stroke Ischemia +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

stroke-ischaemic

no interventions

No interventions assigned to this group

stroke -haemorrhagic

no intervention

No interventions assigned to this group

stroke: not confirmed

no intervention

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged \>18 years of age presenting within 9 hours of onset of symptoms will be recruited from the hyperacute stroke unit at UCLH.
* Patients in whom stroke has been excluded or in whom intracerebral haemorrhage has been diagnosed are to be included as 'controls'. The definitive diagnosis will not be immediately obvious at presentation.
* Written consent will be obtained from patients or their nearest relative, particularly in patients with aphasia/dysphasia.